Novavax, Inc. (NASDAQ: NVAX): Do Not Miss The Gain Train
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $3.89, with 3.71 million shares of worth about $14.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -41.33% during that period and on April 17, 2024 the price saw a loss […]
Is Novavax, Inc. (NASDAQ: NVAX) Proving The Doubters Wrong?
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $4.26, with 5.29 million shares of worth about $22.53 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -40.67% during that period and on April 10, 2024 the price saw a loss […]
Reviewing The Case For Novavax, Inc. (NVAX) Going Higher
Currently, there are 139.51M common shares owned by the public and among those 131.81M shares have been available to trade. The company’s stock has a 5-day price change of -5.82% and -5.62% over the past three months. NVAX shares are trading -5.62% year to date (YTD), with the 12-month market performance down to -31.26% lower. […]
These Numbers Could Change Investor Views For Novavax, Inc. (NASDAQ: NVAX)
Currently, there are 139.51M common shares owned by the public and among those 131.81M shares have been available to trade. The company’s stock has a 5-day price change of -4.66% and -6.92% over the past three months. NVAX shares are trading -1.88% year to date (YTD), with the 12-month market performance down to -22.02% lower. […]
There Is Clear Momentum For Novavax, Inc. (NASDAQ: NVAX)
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $4.83, with 9.16 million shares of worth about $44.27 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -37.11% during that period and on March 20, 2024 the price saw a loss […]
Novavax, Inc. (NVAX) Testing Investors’ Patience Right Now
Currently, there are 139.51M common shares owned by the public and among those 131.86M shares have been available to trade. The company’s stock has a 5-day price change of -6.56% and -7.23% over the past three months. NVAX shares are trading 6.87% year to date (YTD), with the 12-month market performance down to -21.92% lower. […]
Do Novavax, Inc. (NASDAQ: NVAX) Fit In A Value Investing Philosophy?
Currently, there are 139.51M common shares owned by the public and among those 131.87M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]
Novavax, Inc. (NASDAQ: NVAX) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]
An Important Check-Up On Novavax, Inc. (NASDAQ: NVAX)
Novavax, Inc. (NVAX) concluded trading on Wednesday at a closing price of $3.98, with 4.81 million shares of worth about $19.16 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -50.68% during that period and on Wednesday the price saw a loss of about […]
Novavax, Inc. (NASDAQ: NVAX) Has Another Chance To Impress You
Currently, there are 118.79M common shares owned by the public and among those 111.93M shares have been available to trade. Insiders at the company have transacted a total of 32 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 21 of these insider trades were purchases, […]
